[HTML] nih.gov

[HTML][HTML] Perspective adjunctive therapies for COVID-19: beyond antiviral therapy

P Ho, JQ Zheng, CC Wu, YC Hou, WC Liu… - … Journal of Medical …, 2021 - ncbi.nlm.nih.gov
Abstract The coronavirus disease 2019 (COVID-19) pandemic is the largest health crisis
ever faced worldwide. It has resulted in great health and economic costs because no …
被引用次数：27 相关文章 所有 9 个版本
[HTML] jddtonline.info

[HTML][HTML] Immunomodulators for curtailing COVID-19: a positive approach

SA Bhat, SA Rather, A Iqbal, HA Qureshi… - Journal of drug delivery …, 2020 - jddtonline.info
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is highly infectious,
spreading swiftly from man to man which has not been previously recognized in humans …
被引用次数：19 相关文章 所有 8 个版本
[HTML] nih.gov

[HTML][HTML] A comprehensive review on pharmacologic agents, immunotherapies and supportive therapeutics for COVID-19

K Sharun, R Tiwari, MI Yatoo, S Natesan, D Megawati… - Narra J, 2022 - ncbi.nlm.nih.gov
The emergence of coronavirus disease 2019 (COVID-19), caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has affected many countries throughout …
被引用次数：34 相关文章 所有 12 个版本
[HTML] nih.gov

Therapeutic Development and Drugs for the Treatment of COVID-19

VK Maurya, S Kumar, MLB Bhatt, SK Saxena - Coronavirus Disease 2019 …, 2020 - Springer
Abstract SARS-CoV-2/novel coronavirus (2019-nCoV) is a new strain that has recently been
confirmed in Wuhan City, Hubei Province of China, and spreads to more than 165 countries …
被引用次数：38 相关文章 所有 23 个版本

COVID-19 outbreak and emerging management through pharmaceutical therapeutic strategy

MH Rahman, R Akter, T Behl… - Current …, 2020 - ingentaconnect.com
The latest SARS COV2 coronavirus contributes to a pandemic of millions of COVID-19. As
there is no defensive immunity in humans and a virus can overcome inborn immune …
被引用次数：21 相关文章 所有 4 个版本
[HTML] nih.gov

A global picture: therapeutic perspectives for COVID-19

VP Chavda, C Kapadia, S Soni, R Prajapati… - …, 2022 - Taylor & Francis
The COVID-19 pandemic is a lethal virus outbreak by severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2), which has severely affected human lives and the global …
被引用次数：81 相关文章 所有 8 个版本

Current paradigms in COVID-19 research: proposed treatment strategies, recent trends and future directions

AK Sharma, V Sharma, A Sharma… - Current medicinal …, 2021 - ingentaconnect.com
Background: Recent pandemic of coronavirus disease caused by a novel coronavirus SARS-
CoV-2 in humans is the third outbreak by this family of viruses leading to an acute …
被引用次数：9 相关文章 所有 5 个版本
[HTML] frontiersin.org

[HTML][HTML] Traditional herbal medicines, bioactive metabolites, and plant products against COVID-19: update on clinical trials and mechanism of actions

S Alam, MMR Sarker, S Afrin, FT Richi… - Frontiers in …, 2021 - frontiersin.org
SARS-CoV-2 is the latest worldwide pandemic declared by the World Health Organization
and there is no established anti-COVID-19 drug to combat this notorious situation except …
被引用次数：99 相关文章 所有 8 个版本
[HTML] sciencedirect.com

[HTML][HTML] Emerging pharmacotherapies for COVID-19

R Salvi, P Patankar - Biomedicine & Pharmacotherapy, 2020 - Elsevier
Abstract Novel Corona-virus Disease 2019 (nCOVID 19) is caused by a novel virulent
corona virus and leads to potentially fatal virulent pneumonia and severe respiratory distress …
被引用次数：98 相关文章 所有 6 个版本
[HTML] frontiersin.org

[HTML][HTML] Medicinal plants as sources of active molecules against COVID-19

B Benarba, A Pandiella - Frontiers in pharmacology, 2020 - frontiersin.org
The Severe Acute Respiratory Syndrome-related Coronavirus 2 (SARS-CoV-2) or novel
coronavirus (COVID-19) infection has been declared world pandemic causing a worrisome …
被引用次数：217 相关文章 所有 11 个版本